Human GM-CSF Antibody Summary
Ala18-Glu144
Accession # P04141
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
GMCSF in Human PBMCs. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) was detected in human peripheral blood mononuclear cells (PBMCs) using Human GM-CSF Monoclonal Antibody (Catalog # MAB215) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # NL007) and counterstained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Non-adherent Cells.
Cell Proliferation Induced by GM‑CSF and Neutralization by Human GM‑CSF Antibody. Recombinant Human GM-CSF (Catalog # 215-GM) stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line) as measured by Resazurin (Catalog # AR002). Proliferation elicited by Recombinant Human GM-CSF (0.1 ng/mL) is neutralized (green line) by increasing concentrations of Human GM-CSF Monoclonal Antibody (Catalog # MAB215). The ND50 is typically 0.075-0.45 µg/mL.
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: GM-CSF
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is a growth factor produced by a variety of lymphoid cells. It binds to receptor heterodimers consisting of a GM-CSF-specific alpha chain and the common beta chain that is shared by the high-affinity receptors for IL-3 and IL-5.
Product Datasheets
Citations for Human GM-CSF Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
25
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance
Authors: Zheng N, Fang J, Xue G et al.
Cancer cell
-
Suppressive myeloid cells are expanded by biliary tract cancer-derived cytokines in vitro and associate with aggressive disease
Authors: MB Ware, MY Zaidi, J Yang, MK Turgeon, A Krasinskas, TA Mace, K Keenan, MR Farren, AN Ruggieri, Y Li, C Zhang, Z Chen, GS Young, O Elnaggar, Z Che, SK Maithel, T Bekaii-Saa, B El-Rayes, GB Lesinski
Br. J. Cancer, 2020-08-04;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Metabolic and non-metabolic liver zonation is established non-synchronously and requires sinusoidal Wnts
Authors: Ruihua Ma, Angelica S Martínez-Ramírez, Thomas L Borders, Fanding Gao, Beatriz Sosa-Pineda
eLife
-
Neutrophil Activities in Human Ocular Toxoplasmosis: An In Vitro Study With Human Cells
Authors: LM Ashander, S Lie, Y Ma, E Rochet, JM Washington, JM Furtado, B Appukuttan, JR Smith
Invest. Ophthalmol. Vis. Sci., 2019-11-01;60(14):4652-4660.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
Authors: SE Logue, EP McGrath, P Cleary, S Greene, K Mnich, A Almanza, E Chevet, RM Dwyer, A Oommen, P Legembre, F Godey, EC Madden, B Leuzzi, J Obacz, Q Zeng, JB Patterson, R Jäger, AM Gorman, A Samali
Nat Commun, 2018-08-15;9(1):3267.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases
Authors: B Gril, AN Paranjape, S Woditschka, E Hua, EL Dolan, J Hanson, X Wu, W Kloc, E Izycka-Swi, R Duchnowska, R P?ksa, W Biernat, J Jassem, N Nayyar, PK Brastianos, OM Hall, CJ Peer, WD Figg, GT Pauly, C Robinson, S Difilippan, E Bialecki, P Metellus, JP Schneider, PS Steeg
Psychoneuroendocrinology, 2018-07-13;9(1):2705.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Activation of neutrophils by Chlamydia trachomatis-infected epithelial cells is modulated by the chlamydial plasmid
Authors: S Lehr, J Vier, G Häcker, S Kirschnek
Microbes Infect., 2018-03-02;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Epstein-Barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages
Authors: D Huang, S Song, ZZ Wu, W Wu, X Cui, JN Chen, MS Zeng, S Su
Cancer Res., 2017-05-08;0(0):.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
Thyroid Transcription Factor 1 Reprograms Angiogenic Activities of Secretome
Authors: Lauren W. Wood, Nicole I. Cox, Cody A. Phelps, Shao-Chiang Lai, Arjun Poddar, Conover Talbot et al.
Scientific Reports
-
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Authors: Spampinato S, Obermeier B, Cotleur A, Love A, Takeshita Y, Sano Y, Kanda T, Ransohoff R
PLoS ONE, 2015-07-21;10(7):e0133392.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
GM-CSF promotes migration of human monocytes across the blood brain barrier.
Authors: Vogel D, Kooij G, Heijnen P, Breur M, Peferoen L, van der Valk P, de Vries H, Amor S, Dijkstra C
Eur J Immunol, 2015-05-03;45(6):1808-19.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis.
Authors: Weber G, Chousterman B, Hilgendorf I, Robbins C, Theurl I, Gerhardt L, Iwamoto Y, Quach T, Ali M, Chen J, Rothstein T, Nahrendorf M, Weissleder R, Swirski F
J Exp Med, 2014-05-12;211(6):1243-56.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.
Authors: Su S, Liu Q, Chen J, Chen J, Chen F, He C, Huang D, Wu W, Lin L, Huang W, Zhang J, Cui X, Zheng F, Li H, Yao H, Su F, Song E
Cancer Cell, 2014-05-12;25(5):605-20.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
BCR-ABL-induced deregulation of the IL-33/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients.
Authors: Levescot A, Flamant S, Basbous S, Jacomet F, Feraud O, Anne Bourgeois E, Bonnet M, Giraud C, Roy L, Barra A, Chomel J, Turhan A, Guilhot F, Girard J, Gombert J, Herbelin A
Cancer Res, 2014-03-27;74(10):2669-76.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells.
Authors: Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, Barra C, Comerma L, Chudnovskiy A, Gentile M, Llige D, Cols M, Serrano S, Arostegui J, Juan M, Yague J, Merad M, Fagarasan S, Cerutti A
Nat Immunol, 2014-02-23;15(4):354-64.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression
Authors: Claudia M. Gutschalk, Archana K. Yanamandra, Nina Linde, Alice Meides, Sofia Depner, Margareta M. Mueller
Cancer Medicine
-
HIV-1–Infected Peripheral Blood Mononuclear Cells Enhance Neutrophil Survival and HLA-DR Expression Via Increased Production of GM-CSF: Implications for HIV-1 Infection
Authors: Jun Fu, Beverly E. Sha, Larry L. Thomas
JAIDS Journal of Acquired Immune Deficiency Syndromes
-
The implication of aberrant GM-CSF expression in decidual cells in the pathogenesis of preeclampsia.
Authors: Huang SJ, Zenclussen AC, Chen CP, Basar M, Yang H, Arcuri F, Li M, Kocamaz E, Buchwalder L, Rahman M, Kayisli U, Schatz F, Toti P, Lockwood CJ
Am. J. Pathol., 2010-09-09;177(5):2472-82.
Species: Human
Sample Types: Whole Cells, Whole Tissue
Applications: IHC-Fr, IHC-P, Neutralization -
Regulation of human skin pigmentation in situ by repetitive UV exposure: molecular characterization of responses to UVA and/or UVB.
Authors: Choi W, Miyamura Y, Wolber R, Smuda C, Reinhold W, Liu H, Kolbe L, Hearing VJ
J. Invest. Dermatol., 2010-02-11;130(6):1685-96.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P -
Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling.
Authors: Weindl G, Naglik JR, Kaesler S, Biedermann T, Hube B, Korting HC, Schaller M
J. Clin. Invest., 2007-12-01;117(12):3664-3672.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts.
Authors: Hatfield K, Ryningen A, Corbascio M, Bruserud O
Int. J. Cancer, 2006-11-15;119(10):2313-21.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils.
Authors: Filer A, Parsonage G, Smith E, Osborne C, Thomas AM, Curnow SJ, Rainger GE, Raza K, Nash GB, Lord J, Salmon M, Buckley CD
Arthritis Rheum., 2006-07-01;54(7):2096-108.
Species: Human
Sample Types: Cell Culture Supernates, Whole Cells
Applications: Immunodepletion, Neutralization -
Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma.
Authors: Xiao T, Fujita H, Saeki H, Mitsui H, Sugaya M, Tada Y, Kakinuma T, Torii H, Nakamura K, Asahina A, Tamaki K
Cytokine, 2003-08-01;23(4):126-32.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-Fr -
Regulation of the interleukin-5 receptor alpha-subunit on peripheral blood eosinophils from healthy subjects.
Authors: Hellman C, 107334, Hallden G, Hylander B, Lundahl J
Lagging strand gap suppression connects BRCA-mediated fork protection to nucleosome assembly through PCNA-dependent CAF-1 recycling, 2003-01-01;131(1):75-81.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Human T-cell leukemia virus type 2 induces survival and proliferation of CD34(+) TF-1 cells through activation of STAT1 and STAT5 by secretion of interferon-gamma and granulocyte macrophage-colony-stimulating factor.
Authors: Bovolenta C, Pilotti E, Mauri M, Turci M, Ciancianaini P, Fisicaro P, Bertazzoni U, Poli G, Casoli C
Blood, 2002-01-01;99(1):224-31.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human GM-CSF Antibody
Average Rating: 4.5 (Based on 2 Reviews)
Have you used Human GM-CSF Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: